advanced search

Welcome: Guest

log in

Molecular Insight Pharmaceuticals, Inc.-Detailed Product Pipeline

Publication Date September 2009
Publisher Life Science Analytics
Product Type Report
Pages 26
ISBN Number not applicable
Product Code LSA07295
Buy this product or for assistance call +44 20 7060 7474

Summary

Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.

Scope of the reports

Each Life Science Analytics' Pipeline Report provides the user with real detail on a company's pipeline.

In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company's product pipeline and disease hub classification.

Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company's deals and alliances and recent corporate news including key milestones.

Key benefits

  • Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
  • Keep track of your competitors and partners by better understanding their product pipeline.
  • Monitor a company's research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.

Content

  • Business Summary
  • Headquarters
  • Financials
  • Product Glance
    • Products by Phase of Development
    • Products by Disease Hub Classification
    • Products by Indication
  • Product Pipeline
  • Product Details
  • Recent Updates
    • Company Announcements
    • Product Updates
Delivery Details

PDF:Delivered by email usually within 4 to 8 UK business hours.

PRINT/CD-ROM:Despatched within 1 to 2 working days.

Industry Events

2nd International Conference on Drug Discovery and Therapy

01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>